RCM
DGX icon

Riverhead Capital Management’s Quest Diagnostics DGX Stock Holding History

Riverhead Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$5.41M Buy
50,555
+4,350
+9% +$447K 0.2% 129
2019
Q2 		$4.7M Sell
46,205
-5,150
-10% -$495K 0.17% 153
2019
Q1 		$4.62M Buy
51,355
+14,100
+38% +$1.22M 0.19% 155
2018
Q4 		$3.1M Buy
37,255
+10,637
+40% +$997K 0.14% 202
2018
Q3 		$2.87M Sell
26,618
-12,200
-31% -$1.34M 0.1% 256
2018
Q2 		$4.27M Sell
38,818
-7,329
-16% -$763K 0.17% 170
2018
Q1 		$4.63M Sell
46,147
-4,609
-9% -$472K 0.19% 138
2017
Q4 		$5M Sell
50,756
-15,959
-24% -$1.51M 0.21% 127
2017
Q3 		$6.25M Sell
66,715
-1,780
-3% -$189K 0.29% 86
2017
Q2 		$7.61M Buy
68,495
+31,441
+85% +$3.32M 0.38% 54
2017
Q1 		$3.64M Sell
37,054
-12,501
-25% -$1.19M 0.2% 154
2016
Q4 		$4.55M Buy
49,555
+13,300
+37% +$1.15M 0.28% 90
2016
Q3 		$3.07M Buy
36,255
+35,133
+3,131% +$2.95M 0.2% 148
2016
Q2 		$33K Sell
1,122
-128,616
-99% -$9.79M ﹤0.01% 1371
2016
Q1 		$9.27M Sell
129,738
-42,873
-25% -$2.88M 0.13% 210
2015
Q4 		$12.3M Buy
172,611
+80,266
+87% +$5.4M 0.18% 143
2015
Q3 		$5.68M Sell
92,345
-1,960
-2% -$137K 0.09% 284
2015
Q2 		$6.84M Buy
94,305
+6,210
+7% +$459K 0.1% 267
2015
Q1 		$6.77M Buy
88,095
+47,522
+117% +$3.4M 0.1% 262
2014
Q4 		$2.72M Buy
40,573
+2,832
+8% +$179K 0.04% 427
2014
Q3 		$2.29M Buy
37,741
+3,282
+10% +$202K 0.04% 436
2014
Q2 		$2.02M Buy
34,459
+3,859
+13% +$226K 0.04% 450
2014
Q1 		$1.77M Sell
30,600
-68,172
-69% -$3.65M 0.04% 435
2013
Q4 		$5.29M Sell
98,772
-57,228
-37% -$3.39M 0.14% 208
2013
Q3 		$9.64M Buy
156,000
+83,000
+114% +$4.97M 0.31% 93
2013
Q2 		$4.43M Buy
+73,000
New +$4.35M 0.15% 175

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Riverhead Capital Management's DGX Position: Q3 2019 in Review

Riverhead Capital Management increased its Quest Diagnostics (DGX) stake by 9.4% in Q3 2019, buying an estimated $447K and bringing the position to 50,555 shares worth $5.41M. The position accounts for 0.2% of the portfolio, ranked #129.

Riverhead Capital Management first reported a position in DGX in Q2 2013 and has held it in 26 quarters since. The position peaked at $12.3M in Q4 2015. 677 funds tracked by Wall St. Rank hold DGX as of Q3 2019.

  • Riverhead Capital Management held 50,555 shares of Quest Diagnostics worth $5.41M as of Q3 2019.
  • Riverhead Capital Management bought 4,350 Quest Diagnostics shares in Q3 2019, an estimated $447K.
  • Quest Diagnostics made up 0.2% of Riverhead Capital Management's portfolio in Q3 2019, its #129 holding.
  • Riverhead Capital Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 26 quarters since.
  • Riverhead Capital Management's Quest Diagnostics position peaked at $12.3M in Q4 2015.
  • 677 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.